Hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose
- 1 June 1998
- journal article
- clinical trial
- Published by Elsevier in Respiratory Medicine
- Vol. 92, 23-31
- https://doi.org/10.1016/s0954-6111(98)90214-1
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- In Vivo Measurements of Aerosol Dose and Distribution: Clinical RelevanceJournal of Aerosol Medicine, 1996
- Bioequivalence of inhaled drugsEuropean Respiratory Journal, 1995
- Assessing equivalence of inhaled drugsRespiratory Medicine, 1995
- Clinical equivalence of a novel non-chlorofluorocarbon-containing salbutamol sulfate metered-dose inhaler and a conventional chlorofluorocarbon inhaler in patients with asthmaJournal of Allergy and Clinical Immunology, 1995
- Inhaled Glucocorticoids for AsthmaNew England Journal of Medicine, 1995
- Standards for Bioequivalence of Inhaled ProductsClinical Pharmacokinetics, 1994
- Clinical pharmacology of corticosteroids in bronchial asthmaPharmacology & Therapeutics, 1993
- Bioequivalence of metered-dose inhaled medicationsJournal of Allergy and Clinical Immunology, 1993
- A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailabilityJournal of Pharmacokinetics and Biopharmaceutics, 1987
- Bioequivalence Testing -- A Need to RethinkPublished by JSTOR ,1981